在1型糖尿病治疗中,脂肪酸衍生中酶体干细胞/干细胞
Vanshika Sood1,2,3, Hannah Ricioli1,4, George Chigozie Njoku1,5
1Translational Type 1 Diabetes Research, Department of Clinical and Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
Communications biology
|July 23, 2025
概括
脂肪组织衍生的介酶体 stromal/干细胞通过改善β细胞功能和移植接收来改善1型糖尿病治疗的前景. 需要进一步的研究来克服标准化和质量控制方面的挑战,以便广泛应用.
科学领域:
- 干细胞疗法是一种干细胞疗法.
- 免疫调节是一种免疫调节.
- 糖尿病研究研究 糖尿病研究
背景情况:
- 脂肪组织衍生的介质细胞/干细胞 (ADMSCs) 为1型糖尿病 (T1D) 提供了一种新的治疗方法.
- ADMSCs具有免疫调节和再生能力,与其他干细胞来源相比,可能更容易获得.
研究的目的:
- 审查目前对T1D的ADMSC治疗方法的知识和最近的结果.
- 在基于ADMSC的T1D治疗中确定未来研究的挑战和领域.
主要方法:
- 在T1D动物模型和临床试验中对ADMSC应用的文献综述.
- 对ADMSC有效性和局限性的现有数据的综合.
主要成果:
- 在临床前和临床研究中,ADMSC疗法已经证明减少了胰岛素依赖,增强了β细胞质量,改善了小岛移植的存活率.
- 报告的好处包括调节免疫反应和促进组织再生.
结论:
- ADMSCs对1型糖尿病具有显著的治疗潜力.
- 质量控制,标准化和功能异质性等挑战需要进一步调查,以促进临床翻译.
更多相关视频
08:09Isolation of Rat Adipose Tissue Mesenchymal Stem Cells for Differentiation into Insulin-producing Cells
Published on: August 29, 2022
7.7K
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
3.1K
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Tissue Renewal without Stem Cells
1.8K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
1.8K
